Martin Michaelis
Impact in
- Pharmacology top 0.5%
- Pharmacological Effects of Natural Compounds
- Physiology top 1%
- Pain Mechanisms and Treatments
Papers in
- Neurology 41
- Neuroblastoma Research and Treatments 35
- Co-authors
- Jindřich ČinátlWilfrid JänigMarshall DevorHans Wilhelm DoerrH. W. DoerrFlorian RothweilerElspeth M. McLachlanKlaus Langer
- Journals
- Medical Microbiology and Immunology (11 papers)Cells (7 papers)Neoplasia (6 papers)Cancers (6 papers)Biochemical Pharmacology (6 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Martin Michaelis
225 papers receiving 9.6k citations
Hit Papers
Peers
Comparison fields: 5 of 172
- Pharmacology 651
- Physiology 1.7k
- Neurology 941
- Infectious Diseases 1.1k
- Molecular Biology 3.7k
Countries citing papers authored by Martin Michaelis
This map shows the geographic impact of Martin Michaelis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Michaelis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Michaelis more than expected).
Fields of papers citing papers by Martin Michaelis
This network shows the impact of papers produced by Martin Michaelis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Michaelis. The network helps show where Martin Michaelis may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin Michaelis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 9 | |
| 7 | 2021 | 9 | |
| 8 | 2020 | 75 | |
| 9 | 2020 | 54 | |
| 10 | 2019 | 3 | |
| 11 | 2018 | 74 | |
| 12 | 2016 | 4 | |
| 13 | 2013 | 23 | |
| 14 | A multi-label correlation-based feature selection method for the classification of neuroblastoma microarray data. | 2012 | 8 |
| 15 | 2010 | 8 | |
| 16 | 2009 | 83 | |
| 17 | 2007 | 32 | |
| 18 | Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization. | 2005 | 29 |
| 19 | Evaluation of bitterness in Cheddar cheese. | 2000 | 11 |
| 20 | 1996 | 209 |
About Martin Michaelis
Martin Michaelis is a scholar working on Neurology, Infectious Diseases, Oncology, Immunology and Molecular Biology, having authored 232 papers that have together received 9.8k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (35 papers), Cancer therapeutics and mechanisms (26 papers), Cytomegalovirus and herpesvirus research (17 papers), Immune Cell Function and Interaction (15 papers), Influenza Virus Research Studies (14 papers), Pain Mechanisms and Treatments (14 papers), Drug Transport and Resistance Mechanisms (13 papers) and Protein Degradation and Inhibitors (13 papers). The work is most often cited by research in Pharmacology (651 citations), Physiology (1.7k citations), Neurology (941 citations), Infectious Diseases (1.1k citations) and Molecular Biology (3.7k citations). Martin Michaelis has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Jindřich Činátl, Wilfrid Jänig, Marshall Devor, Hans Wilhelm Doerr, H. W. Doerr, Florian Rothweiler, Elspeth M. McLachlan, Klaus Langer, Roman A. Blaheta and Patchima Sithisarn. Their work appears in journals such as Medical Microbiology and Immunology, Cells, Neoplasia, Cancers and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.